Context: For many patients, adhering to postmenopausal osteoporosis treatment is a challenge. Higher treatment satisfaction is associated with greater persistence with these therapies, which is associated with better outcomes.

Objective: To evaluate the change in treatment satisfaction in postmenopausal women who were suboptimally adherent to daily or

Conclusions: Women with low adherence to oral bisphosphonates reported greater treatment satisfaction when transitioned to denosumab versus switching to a monthly oral bisphosphonate.

READ FULL ARTICLE Curated publisher From press.endocrine.org